estimated 500 billion US dollars.
11 Moreover, natural genetic resources play a significant role in research, the cosmetics industry, biotechnology and agriculture.
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For example, Eli Lilly & Company isolated two extracts from Madagascar's rosy periwinkle (vinblastine and vincristin) that have since become powerful drugs -one to treat childhood leukaemia, and the other to treat Hodgkin's disease. Together, these drugs generate over 200 billion US dollars in revenue each year.
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Countries that are rich in traditional knowledge should take every possible action to protect their resources. As traditional knowledge is usually undocumented, it is far too easy, for example, for someone to "discover" a "new" plant and file a patent application. The novelty of traditional knowledge allows it to be patented with no compensation given to the actual inventors. briefly examines additional problems in applying international patent law to traditional knowledge. And finally, emerging protection systems are also considered.
Defining indigenous people, traditional knowledge, patents and the concept of biopiracy
There are many, and often competing, definitions of indigenous peoples. The Martinez Cobo Report prepared by the United Nations defines indigenous peoples as "those which, having a historical continuity with pre-invasion and pre-colonial Another important expression is "biopiracy," which may be defined as the misappropriation of traditional knowledge for the purpose of seeking exclusive patent ownership over that knowledge. 23 It could also be described as the process through
The road to biotechnology patents in the United States and Europe
To analyse the influence of patent law on traditional knowledge, it is necessary to examine the conditions for patentability. To do this, it is worthwhile to take a brief look at some significant cases and legal regulations.
The protection of plant varieties and plant genetic resources in the United States
Patent law in the United States has been shifting and adapting itself to the evolution of technology and science, and to economic trends. 26 sets the global minimum for patentability. It is a basic framework that protects the intellectual property rights of individuals and corporations across the member-states of the World Trade Organisation. TRIPS is recognised as an "impressive" agreement with "comprehensive scope and coverage," leading some to argue that it is the "most important multilateral instrument in this field." 60 According to Article 1 of TRIPS, members are not obliged to implement more extensive protection in their domestic law than that required by TRIPS. 61 Rather, what is important is that TRIPS has established, for the first time in this era of patents, global minimum standards for patentability. 62 These provisions provide that:
1. Subject to the provisions of paragraphs 2 and 3, patents shall be available for any inventions, whether products or process, in all fields of technology, provided that they are new, involve an inventive step and are capable of industrial application.
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According to paragraphs 2 and 3, members may exclude from patentability:
2. Inventions, the prevention within their territory of the commercial exploitation of which is necessary to protect ordre public or morality, including to protect human, animal or plant life or health or to avoid serious prejudice to the environment, provided that such exclusion is not made merely because the exploitation is prohibited by their law. 3. Diagnostic, therapeutic and surgical methods for the treatment of humans or animals; plants and animals other than micro-organisms, and essentially biological processes for the production of plants or animals other than non-biological and microbiological processes. However, Members shall provide for the protection of plant varieties either by patents or by an effective sui generis system or by any combination thereof.
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However, while Article 27 establishes general global requirements for patentability, it does not provide a universal international definition for the terms "new," "inventive step" or "industrial application." Therefore member-states may apply different interpretations of these terms, which is problematic. TRIPS also does not provide an international standard for "inventive creativity." Thus many developing countries could be patenting the obvious without realising it. Indeed, from the traditional knowledge perspective, the most important aspect of patentability is this criterion of novelty.
The criterion of novelty
Since the TRIPS Agreement does not provide any definition of invention, memberstates are relatively free to frame the policy options in the biological patents' field however they choose. 65 The patent system has thus far established the legal doctrine that only tangible inventions are protectable. 66 However, as stated previously, patents are granted now more and more to inventions that are discoveries of the laws of nature or isolates of natural chemical compounds.
According to Article 52 (1) The major criticism of American patent law on this point is its state-centric nature.
The United States operates under a system of geographically specific notions of printed publications to determine prior art. Scholars argue that American patent law thus "waters down the novelty requirement by patenting inventions known or used in foreign countries as long as they have not been patented in a printed publication."
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Developing countries which do not have strong systems of patent protection could therefore suffer, and traditional knowledge could be exploited in the United States.
Indeed, the cultural and economic damage that this regime could cause to indigenous people is mammoth.
In European patent law, the novelty requirement is treated a bit differently. Under
Article 54(2) of the EPC:
The state of the art shall be held to comprise everything made available to the public by means of a written or oral description, by use in any other way, before the date of filing of the European patent application. Since many developing countries are dependent on biological resources, they support the CBD to prevent the unauthorised appropriation of traditional knowledge and to ensure benefit sharing, rather than to establish a system of positive protection. 98 Article 8(j) of the CBD provides as follows:
Subject to its national legislation, respect, preserve and maintain knowledge, innovations and practices of indigenous and local communities embodying traditional lifestyles relevant for the conservation and sustainable use of biological diversity and promote their wider application with the approval and involvement of the holders of such knowledge, innovations and practices and encourage the equitable sharing of the benefits arising from the utilization of such knowledge, innovations and practices. documented knowledge that appears in a printed publication is beyond patentability.
It therefore fails to be recognised as prior art, and thus cannot be protected from being patented by another party. Finally, even if traditional knowledge in some regions is common knowledge, as it was in the NeemTree or Turmeric case, it may still be patented in some jurisdictions. The reasons are not only that there are very limited prior art searches in the United States, but also that there is no requirement for patent applicants to conduct their own prior art searches before lodging an application.
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Administrative barriers arise in the process of granting patents. It is obvious that indigenous peoples do not possess the appropriate financial resources to fill out a patent application themselves. 119 Moreover, not only administrative but also judicial procedures are often long and costly. According to economists, it would cost a poor country more than two million US dollars to set up the basic infrastructure for administering intellectual property rights. 120 In addition, patent applications also must be written using technical chemical and/or biotechnological terms.
The different strategies for the protection of traditional knowledge
As discussed above, traditional knowledge may be protected under patents.
However, the patent protection of traditional knowledge faces many difficulties. It is therefore worthwhile to briefly consider alternative protection strategies and options.
Models of intellectual property rights
New plant products and varieties of all species of plants may be protected under 
Convention for the Protection of New Varieties of Plants
121 requires a more flexible novelty requirement than patent protection. Article 6(1) of the UPOV provides the following criteria for establishing novelty:
The variety shall be deemed to be new if, at the date of filing of the application for a breeder's right, propagating or harvested material of the variety has not been sold or otherwise disposed of to others, by or with the consent of the breeder, for the purposes of exploitation of the variety (i) in the territory of the Contracting Party in which the application has been filed earlier than one year before that date and (ii) in a territory other than that of the Contracting Party in which the application has been filed earlier that four years or, in the case of trees or of vines, earlier than six years before the said date. All kinds of products, such as furniture, articles of ceramics, and leather and wood products may qualify for the protection of industrial designs. 126 Copyright, in turn, can be used to protect artistic manifestations of holders of traditional knowledge, and could also include literary works like legends, myths, and poems, theatrical works, musical works, and textile compositions.
However, a system based on intellectual property rights at the national level creates only territorial rights, which means that the rights cannot be enforced in an outside, third country. The existence of such a regime therefore does not solve the problem of "biopiracy," as in most cases the appropriation of traditional knowledge is made by foreign entities. 
A sui generis regime of intellectual property rights
Another possible option, which may protect traditional knowledge, is a sui generis system of intellectual property rights. 127 There are several models of possible sui generis legislation. One such model was developed by the Third World Network in the 1994 discussion paper, Community Intellectual Rights Act. 128 Another one, for example, is provided by the Organisation of African Unity. 129 In practice, this kind of protection has not been systematically implemented, but it is strongly supported by many scholars and non-governmental organisations.
As Correa rightly pointed out, when creating a sui generis system it is always a matter of debate if the protection of traditional knowledge should be subsumed under a single and comprehensive regime covering all manifestations of traditional knowledge, or a set of specific regimes adapted to the nature of the subject matter to be protected. 130 A single regime requires the determination of different subject matters, which might be hard to find and which may prove difficult when trying to define common legal rules. 131 Alternatively, a more specific system could, for example, be divided into three parts: artistic creations including folklore, plant genetic resources for food and agriculture, and traditional medicine. Although indigenous people possess the resources and the traditional knowledge to produce a unique set of biological materials, the global community is not only often depriving them to do so but is also devastating biodiversity at a rapid rate. 
